European football: Mourinho grabs rival manager’s face after Turkish Cup defeat
Arne Slot admits he ‘hates’ offside rule that allowed Liverpool’s derby winner
‘Stressful’ debut as Daria Kasatkina appears as Australian player for first time
Italian police increase security at Tesla dealerships after 17 cars destroyed in Rome fire
Donald Trump hits Australian exporters with 10% tariffs in ‘liberation day’ speech
European football: Mourinho grabs rival manager’s face after Turkish Cup defeat
Arne Slot admits he ‘hates’ offside rule that allowed Liverpool’s derby winner
‘Stressful’ debut as Daria Kasatkina appears as Australian player for first time
Italian police increase security at Tesla dealerships after 17 cars destroyed in Rome fire
Donald Trump hits Australian exporters with 10% tariffs in ‘liberation day’ speech
MHRA authorises uses of Casgevy as a potential cure for sickle cell disease and beta thalassemia
Britain’s drugs regulator has approved a groundbreaking treatment for two painful and debilitating lifelong blood disorders, which works by “editing” the gene that causes them.
The Medicines and Healthcare products Regulatory Agency (MHRA) has given the green light for Casgevy to be used to treat sickle cell disease and beta thalassemia.
Notifications
More Stories
Doctors urge government to fight poverty after rise in patients with Victorian diseases
As a geneticist, I will not mourn 23andMe and its jumble of useless health information | Adam Rutherford
NIH sued over ‘ideological purge’ of DEI, Covid and vaccine research